Beta 2-microglobulin in haematological malignancies.
- 28 March 1981
- Vol. 282 (6269), 1013
- https://doi.org/10.1136/bmj.282.6269.1013
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Serum Beta2-Microglobulin in Acute and Chronic LeukaemiaScandinavian Journal of Haematology, 2009
- Urinary excretion of β2-microglobulin in myeloma patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- TNM (1978) in Bladder Cancer: Use and AbuseBritish Journal of Urology, 1980
- Diagnosis of Leukemia or Lymphoma in the Central Nervous System by Beta2-Microglobulin DeterminationNew England Journal of Medicine, 1980
- β2‐Microglobulin in Chronic Lymphocytic LeukaemiaScandinavian Journal of Haematology, 1980
- Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patientsCancer, 1980
- beta 2-Microglobulin in clinical medicine.1980
- Behaviour of Serum β2-Microglobulin and Acute Phase Reactant Proteins in Chronic Lymphocytic LeukaemiaActa Haematologica, 1980
- Serum β2 microglobulin and its prognostic value in lymphomasEuropean Journal of Cancer (1965), 1979
- Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder CarcinomaBritish Journal of Urology, 1976